UNSPSC 51334001: Fluspirilene

This classification denotes an antipsychotic agent and dopamine antagonist with the molecular formula C29H31F2N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier C5QA4GLR9M, chemically known as 1,3,8-triazaspiro(4.5)decan-4-one, 8-(4,4-bis(4-fluorophenyl)butyl)-1-phenyl- but generally known as fluspirilene, which bears US NIH Compound Identifier 3396. European Medicines Agency schedules Fluspirilene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07755MIG.

UNSPSC 51334001 Fluspirilene is a Commodity code that in recent state and local procurement has been applied to purchases of naloxone and drug deactivation systems rather than the pharmaceutical compound the code nominally describes. State and local governments soliciting under this code are primarily county health departments and community health agencies seeking to acquire opioid-overdose reversal medications and related harm-reduction equipment to support public health and emergency response initiatives. The work involves competitive procurement of finished pharmaceutical products and medical devices with defined annual unit requirements, delivery schedules to specified locations, and standard vendor compliance obligations including drug-free workplace certification, E-Verify eligibility verification, and commercial liability insurance.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) in June 2026 seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with a response deadline of July 26, 2026, and quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract structure includes a two-year initial term with a one-year renewal option, and the procurement indicates potential FEMA funding with corresponding federal compliance requirements. The source shows limited recent activity under this code; the single documented opportunity suggests that state and local naloxone and drug-deactivation-system procurement may be tagged to this pharmaceutical code despite the nominal mismatch between the code definition and the actual goods being bought.